(Q43635483)

25 November 2017

title

Expressions of MAGE-A10 and MAGE-A11 in breast cancers and their prognostic significance: a retrospective clinical study (English)

1 reference

25 November 2017

Yishui Lian

1

1 reference

25 November 2017

Meixiang Sang

2

1 reference

25 November 2017

Chunyan Ding

3

1 reference

25 November 2017

Xinliang Zhou

4

1 reference

25 November 2017

Xiaojie Fan

5

1 reference

25 November 2017

Yingying Xu

6

1 reference

25 November 2017

Weihua Lü

7

1 reference

25 November 2017

Baoen Shan

8

1 reference

25 November 2017

publication date

25 December 2011

1 reference

Journal of Cancer Research and Clinical Oncology

25 November 2017

published in

1 reference

25 November 2017

volume

138

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

519-527

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-011-1122-x

25 November 2017

exact match

0 references

cites work

Expression of MAGE genes in primary and metastatic cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

Structure, chromosomal localization, and expression of 12 genes of the MAGE family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

Breast cancer: origins and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

Antitumor activity of HER-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

Melanoma-associated antigen genes - an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

MAGE-A family: attractive targets for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

Cancer/testis antigens, gametogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

Histological and molecular types of breast cancer: is there a unifying taxonomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

Cancer/testis-associated genes: identification, expression profile, and putative function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1122-X

Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.

21 January 2018

1 reference

12 December 2020

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

12 December 2020

Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma

1 reference

12 December 2020

Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation

1 reference

12 December 2020

The cancer/testis genes: review, standardization, and commentary.

1 reference

12 December 2020

Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease

1 reference

12 December 2020

High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer

1 reference

12 December 2020

The melanoma antigen genes--any clues to their functions in normal tissues?

1 reference

12 December 2020

Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family

1 reference

12 December 2020

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

1 reference

12 December 2020

MAGE-A gene expression pattern in primary breast cancer

1 reference

12 December 2020

10.1007/S00432-011-1122-X

Identifiers

DOI

1 reference

release_tu643kca2zfb3lvsqofevmitvq

25 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tu643kca2zfb3lvsqofevmitvq

24 November 2022

mapped directly with Wikidata item

1 reference